{"altmetric_id":2815797,"counts":{"readers":{"mendeley":33,"citeulike":0,"connotea":0},"total":{"posts_count":8},"twitter":{"unique_users_count":8,"unique_users":["manolosesmero","leonorperianez","carzoide","Pro_antibiotic","GrupoPKgen_SEFH","Piedad_L_S","AdisJournals","majo_386"],"posts_count":8}},"selected_quotes":["New Article Alert: PK and PD Drug Interactions Between Antiretrovirals and Oral Contraceptives #pharmacokinetics"],"citation":{"abstract":"More than 50\u00a0% of women living with HIV in low- and middle-income countries are of reproductive age, but there are limitations to the administration of oral contraception for HIV-infected women receiving antiretroviral therapy due to drug-drug interactions caused by metabolism via the cytochrome P450 isoenzymes and glucuronidation. However, with the development of newer antiretrovirals that use alternative metabolic pathways, options for contraception in HIV-positive women are increasing. This paper aims to review the literature on the pharmacokinetics and pharmacodynamics of oral hormonal contraceptives when given with antiretroviral agents, including those currently used in developed countries, older ones that might still be used in salvage regimens, or those used in resource-limited settings, as well as newer drugs. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs), the usual backbone to most combined antiretroviral treatments (cARTs) are characterised by a low potential for drug-drug interactions with oral contraceptives. On the other hand non-NRTIs (NNRTIs) and protease inhibitors (PIs) may interact with oral contraceptives. Of the NNRTIs, efavirenz and nevirapine have been demonstrated to cause drug-drug interactions; however, etravirine and rilpivirine appear safe to use without dose adjustment. PIs boosted with ritonavir are not recommended to be used with oral contraceptives, with the exception of boosted atazanavir which should be used with doses of at least 35\u00a0\u00b5g of estrogen. Maraviroc, an entry inhibitor, is safe for co-administration with oral contraceptives, as are the integrase inhibitors (INIs) raltegravir and dolutegravir. However, the INI elvitegravir, which is given in combination with cobicistat, requires a dose of estrogen of at least 30\u00a0\u00b5g. Despite the growing evidence in this field, data are still lacking in terms of large cohort studies, randomised trials and correlations to real clinical outcomes, such as pregnancy rates, in women on antiretrovirals and hormonal contraception.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ea3cf058f610002571","authors":["Victoria Tittle","Lauren Bull","Marta Boffito","Nneka Nwokolo"],"doi":"10.1007\/s40262-014-0204-8","first_seen_on":"2014-10-28T06:27:40+00:00","funders":["niehs"],"issns":["1179-1926","0312-5963"],"journal":"Clinical Pharmacokinetics","last_mentioned_on":1420545909,"links":["http:\/\/link.springer.com\/article\/10.1007\/s40262-014-0204-8"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs40262-014-0204-8.pdf","pmid":"25331712","pubdate":"2014-10-21T00:00:00+00:00","publisher":"Springer International Publishing","publisher_subjects":[{"name":"Internal Medicine","scheme":"springer"},{"name":"Medicine & Public Health","scheme":"springer"},{"name":"Pharmacology\/Toxicology","scheme":"springer"},{"name":"Pharmacotherapy","scheme":"springer"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"title":"Pharmacokinetic and Pharmacodynamic Drug Interactions Between Antiretrovirals and Oral Contraceptives","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/pharmacokinetic-pharmacodynamic-drug-interactions-between-antiretrovirals-oral-contraceptives"},"altmetric_score":{"score":4.45,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.45},"context_for_score":{"all":{"total_number_of_other_articles":5036385,"mean":5.9659709716306,"rank":1011322,"this_scored_higher_than_pct":79,"this_scored_higher_than":4019924,"rank_type":"exact","sample_size":5036385,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":143884,"mean":8.6905101367085,"rank":34335,"this_scored_higher_than_pct":75,"this_scored_higher_than":109327,"rank_type":"exact","sample_size":143884,"percentile":75},"this_journal":{"total_number_of_other_articles":423,"mean":2.9478767772512,"rank":50,"this_scored_higher_than_pct":88,"this_scored_higher_than":373,"rank_type":"exact","sample_size":423,"percentile":88},"similar_age_this_journal_3m":{"total_number_of_other_articles":16,"mean":2.0036,"rank":3,"this_scored_higher_than_pct":81,"this_scored_higher_than":13,"rank_type":"exact","sample_size":16,"percentile":81}}},"demographics":{"poster_types":{"member_of_the_public":6,"practitioner":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":3,"Members of the public":5}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Librarian":1,"Researcher":5,"Student  > Doctoral Student":4,"Student  > Ph. D. Student":4,"Student  > Postgraduate":3,"Other":1,"Student  > Master":5,"Student  > Bachelor":3,"Lecturer":2,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":19,"Social Sciences":2,"Physics and Astronomy":1,"Agricultural and Biological Sciences":2,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":4}}},"geo":{"twitter":{"ES":4},"mendeley":{"CH":1,"PT":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/manolosesmero\/status\/526055671473901568","license":"datasift","rt":["GrupoPKgen_SEFH"],"citation_ids":[2815797],"posted_on":"2014-10-25T17:00:20+00:00","author":{"name":"JM Mart\u00ednez Sesmero","image":"https:\/\/pbs.twimg.com\/profile_images\/770955943777632256\/SASoA1xC_normal.jpg","description":"Hospital Pharmacist interested in #Research #Development #Innovation.\nAlways on the run...","id_on_source":"manolosesmero","tweeter_id":"398080943","geo":{"lt":39.8581,"ln":-4.02263,"country":"ES"},"followers":2239},"tweet_id":"526055671473901568"},{"url":"https:\/\/twitter.com\/leonorperianez\/status\/525946786503208960","license":"datasift","rt":["GrupoPKgen_SEFH"],"citation_ids":[2815797],"posted_on":"2014-10-25T09:47:40+00:00","author":{"name":"LeonorPeria\u00f1ez","url":"https:\/\/www.linkedin.com\/profile\/view?id=166183301","image":"https:\/\/pbs.twimg.com\/profile_images\/822707377141141505\/BUY0dGbv_normal.jpg","description":"Farmac\u00e9utica especialista hospitalaria.\nComit\u00e9 t\u00e9cnico coordinador PRAN-AEM y CAIB.\nGrupo coordinador AFinf.\nM\u00e1ster enf infcc en paciente cr\u00edtico.\nMenorquina!","id_on_source":"leonorperianez","tweeter_id":"1125231541","geo":{"lt":39.56951,"ln":2.64745,"country":"ES"},"followers":1004},"tweet_id":"525946786503208960"},{"url":"https:\/\/twitter.com\/carzoide\/status\/526048300794134528","license":"datasift","rt":["GrupoPKgen_SEFH"],"citation_ids":[2815797],"posted_on":"2014-10-25T16:31:03+00:00","author":{"name":"Carmen Garcia","url":"http:\/\/www.madrid.org\/hospital12octubre\/farmacia","image":"https:\/\/pbs.twimg.com\/profile_images\/716295379113914368\/3SWJpLh5_normal.jpg","description":"Farmac\u00e9utica especialista en Farmacia Hospitalaria. Centro de Informaci\u00f3n de Medicamentos. Hospital Universitario 12 de Octubre","id_on_source":"carzoide","tweeter_id":"201775983","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":440},"tweet_id":"526048300794134528"},{"url":"https:\/\/twitter.com\/Pro_antibiotic\/status\/526669480773300224","license":"datasift","citation_ids":[2815797],"posted_on":"2014-10-27T09:39:23+00:00","author":{"name":"PRO Antibiotic","image":"https:\/\/pbs.twimg.com\/profile_images\/446326416406491136\/CdfZ91EW_normal.jpeg","id_on_source":"Pro_antibiotic","tweeter_id":"2422915497","geo":{"lt":null,"ln":null},"followers":677},"tweet_id":"526669480773300224"},{"url":"https:\/\/twitter.com\/GrupoPKgen_SEFH\/status\/525945863848615936","license":"datasift","citation_ids":[2815797],"posted_on":"2014-10-25T09:44:00+00:00","author":{"name":"Grupo PK.gen SEFH","url":"http:\/\/www.sefh.es","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000632170332\/651d4316065a89aa7167d3435dcf039d_normal.jpeg","description":"Grupo de Farmacocin\u00e9tica Cl\u00ednica y Farmacogen\u00e9tica de la Sociedad Espa\u00f1ola de Farmacia Hospitalaria.","id_on_source":"GrupoPKgen_SEFH","tweeter_id":"1963301778","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":1284},"tweet_id":"525945863848615936"},{"url":"https:\/\/twitter.com\/Piedad_L_S\/status\/525958602184728576","license":"datasift","rt":["GrupoPKgen_SEFH"],"citation_ids":[2815797],"posted_on":"2014-10-25T10:34:37+00:00","author":{"name":"Piedad L\u00f3pez","image":"https:\/\/pbs.twimg.com\/profile_images\/488344275365527553\/7T1XuCSA_normal.jpeg","description":"Especialista en Farmacia Hospitalaria. Entre vi\u00f1edos...","id_on_source":"Piedad_L_S","tweeter_id":"1850536530","geo":{"lt":null,"ln":null},"followers":491},"tweet_id":"525958602184728576"},{"url":"https:\/\/twitter.com\/AdisJournals\/status\/552435699459559424","license":"datasift","citation_ids":[2815797],"posted_on":"2015-01-06T12:05:09+00:00","author":{"name":"AdisJournals","url":"http:\/\/www.adis.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000171081809\/b533ccf6146a63820d89ad820d6bba21_normal.jpeg","description":"Official account of Adis \u2013 publishers of a premier collection of drug-focused medical journals and newsletters. Site notice http:\/\/ow.ly\/jXxkQ","id_on_source":"AdisJournals","tweeter_id":"337605795","followers":474},"tweet_id":"552435699459559424"},{"url":"https:\/\/twitter.com\/majo_386\/status\/526627486541836288","license":"datasift","rt":["GrupoPKgen_SEFH"],"citation_ids":[2815797],"posted_on":"2014-10-27T06:52:31+00:00","author":{"name":"Maria Jose Company","image":"https:\/\/pbs.twimg.com\/profile_images\/587612745274679296\/hY_Xzw3s_normal.jpg","description":"Farmac\u00e9utica especialista en Farmacia Hospitalaria. Siempre ampliando la zona de confort.","id_on_source":"majo_386","tweeter_id":"1485632016","geo":{"lt":null,"ln":null},"followers":175},"tweet_id":"526627486541836288"}]}}